Tüketilen Bazı Probiyotik Preparatların İçerdiği Bakteri Seviyelerinin Belirlenerek PZR ile Doğrulanması

Yazarlar

DOI:

https://doi.org/10.24925/turjaf.v12i1.59-65.6400

Anahtar Kelimeler:

Bifidobacterium spp. - Lactobacillus spp. - Probiyotik mikroorganizmalar - Probiyotik-prebiyotik preparatlar - PZR

Özet

Bu çalışma, takviye olarak kullanılan probiyotik preparatların etikette belirtildiği gibi içerdiği bakterilerin canlılık ve seviyelerinin incelenmesi amacıyla yapılmıştır. Bu amaçla farklımarkalara ait Lactobacillus ve Bifidobacterium türlerini içeren toplam 15 farklı preparat temin edildi. Örnekler Lactobacillus ve Bifidobacterium türlerini yönünden mikrobiyolojik ekime tabii tutuldu. Yapılan mikrobiyolojik analiz sonucunda örneklerin 13’ünde (%87) canlı bakteri saptanırken 2 örnekte (%13) üreme olmadığı gözlemlendi. Lactobacillus spp. içeren probiyotik preparatlarda bakteri sayısı ortalama 5,9×1010 kob/g; Bifidobacterium spp. içeren probiyotik preparatlarda ise bakteri sayısının ortalama 1,3×109 kob/g olduğu görüldü. Gram boyama, katalaz testivekarbonhidrat fermentasyon testi yapılan suşların Polimeraz Zincir Reaksiyonu (PZR) analiziile doğrulamaları yapıldı. PZR analizi sonucunda, 13 örnekte Lactobacillus ve Bifidobacterium türleri tespit edildi. Sonuç olarak tüketime sunulan hazır probiyotik preparatlarda belirtilen suşların varlığı, canlılığı ve miktarı oldukça önemlidir. Etikette yazılan bilgilerin doğruluk payının %87 olduğu yaptığımız çalışmamızda görüldü.

Referanslar

Altuntaş, Y., & Batman, A. (2017). Mikrobiyota ve metabolik sendrom. Türk Kardiyoloji Derneği Arşivi, 45(3). doi: 10.5543/tkda.2016.72461

ANSI/AAMI/ISO. (1998). Sterilization of Health Care Products Microbiological methods-Part 2: Tests of sterility performed in the validation of a sterilization process, 11737-2.

Anuradha, S., & Rajeshwari, K. (2005). Probiotics in health and disease. Journal, Indian Academy of Clinical Medicine, 6(1), 67-72.

Arda, M., Minbay, A., Leloğlu, N., Aydın, N., Akay, Ö., Ilgaz, A., & Diker K. S. (2006). Özel Mikrobiyoloji. Medisan Yayınevi. Ankara, 5-9.

Aslan, F. G., & ALTINDİŞ, M. (2017). İnsan mikrobiyom projesi, mikrobiyotanın geleceği ve kişiye özel tıp uygulamaları. Journal of Biotechnology and Strategic Health Research, 1, 1-6.

Aureli, P., Fiore, A., Scalfaro, C., Casale, M., & Franciosa, G. (2010). National survey outcomes on commercial probiotic food supplements in Italy. International Journal of Food Microbiology, 137(2-3), 265-273. DOI: 10.1016/j.ijfoodmicro.2009.12.016

Bunešová, V., Vlková, E., Rada, V., Hovorková, P., Ročková, Š., & Kmeť, V. (2014). Direct identification of bifidobacteria from probiotic supplements. Czech Journal of Food Sciences, 32(2), 132. DOI: 10.17221/291/2013-CJFS

Byun, R., Nadkarni, M. A., Chhour, K. L., Martin, F. E., Jacques, N. A., & Hunter, N. (2004). Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. Journal of clinical microbiology, 42(7), 3128-3136. DOI: 10.1128/JCM.42.7.3128-3136.2004

Crook, W. (1992). Cronic Fatigue Syndrome and the Yeast Connection. Jackson, TN: Professional Books Future Healt. Drago L, Rodighiero V, Celeste T, Rovetto L, De Vecchi E. 2010. Microbiological evaluation of commercial probiotic products available in the USA in 2009. Journal of Chemotherapy, 22(6): 373-377. https://doi.org/10.1179/joc.2010.22.6.373

Dunne, C. (2001). Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflammatory Bowel Diseases, 7(2), 136-145. DOI: 10.1097/00054725-200105000-00010

Durlu Özkaya, F. (2001). Salamura beyaz peynirden izole edilen bazı laktokok, enterekok ve laktobasil suşlarının proteolitik aktivite, bakteriyosin etkenliği ve biyogen amin oluşumu açısından karşılaştırılması.

Gibson, G. R., & Roberfroid, M. B. (1995). Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. The Journal of nutrition, 125(6), 1401-1412. DOI: 10.1093/jn/125.6.1401

Goldstein, E. J., Citron, D. M., Claros, M. C., & Tyrrell, K. L. (2014). Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?. Anaerobe, 25, 1-4. https://doi.org/10.1016/j.anaerobe.2013.10.005

Gomes, A. M., & Malcata, F. X. (1999). Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends in food science & technology, 10(4-5), 139-157. https://doi.org/10.1016/S0924-2244(99)00033-3

Hill, C., Guarner, F., Reid, G., Gibson, G., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H., & Salminen, S. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11: 506. DOI: 10.1038/nrgastro.2014.66

Ichim, T. E., Patel, A. N., & Shafer, K. A. (2016). Experimental support for the effects of a probiotic/digestive enzyme supplement on serum cholesterol concentrations and the intestinal microbiome. Journal of Translational Medicine, 14(1), 1-9. DOI: 10.1186/s12967-016-0945-2

Joint, F.( 2007). Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo- controlled trial. Journal of Allergy and Clinical Immunology, 119(4): 1019-1021. DOI: 10.1016/j.jaci.2006.12.608

Kaur, I. P., Chopra, K., & Saini, A. (2002). Probiotics: potential pharmaceutical applications. European Journal of Pharmaceutical Sciences, 15(1), 1-9. DOI: 10.1016/s0928-0987(01)00209-3

Lilly, D. M., & Stillwell, R. H. (1965). Probiotics: growth-promoting factors produced by microorganisms. Science, 147(3659), 747-748. DOI: 10.1126/science.147.3659.747

Liong, M. T., & Shah, N. P. (2006). Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora, and organic acids in rats. Journal of dairy science, 89(5), 1390-1399. DOI: 10.3168/jds.S0022-0302(06)72207-X

Manning, T. S., & Gibson, G. R. (2004). Prebiotics. Best practice & research clinical gastroenterology, 18(2), 287-298. http://dx.doi.org/10.1016/j.bpg.2003.10.008

Marinova, V. Y., Rasheva, I. K., Kizheva, Y. K., Dermenzhieva, Y. D., & Hristova, P. K. (2019). Microbiological quality of probiotic dietary supplements. Biotechnology & Biotechnological Equipment, 33(1), 834-841. doi/full/10.1080/13102818.2019.1621208

Morovic, W., Hibberd, A. A., Zabel, B., Barrangou, R., & Stahl, B. (2016). Genotyping by PCR and high-throughput sequencing of commercial probiotic products reveals composition biases. Frontiers in microbiology, 7, 1747. https://doi.org/10.3389/fmicb.2016.01747

Patro, J. N., Ramachandran, P., Barnaba, T., Mammel, M. K., Lewis, J. L., & Elkins, C. A. (2016). Culture-independent metagenomic surveillance of commercially available probiotics with high-throughput next-generation sequencing. MSphere, 1(2), 10-1128. DOI: https://doi.org/10.1128/msphere.00057-16

R Fuller. 1992. Probiotics. The scientific basis. Home; Book. Probiotics. Authors: Roy Fuller. Roy Fuller. Intestinal Microecology Consultant, Reading, UK.

Rastall, R. A., & Maitin, V. (2002). Prebiotics and synbiotics: towards the next generation. Current Opinion in Biotechnology, 13(5), 490-496. doi: 10.1016/s0958-1669(02)00365-8

Sanders, M. E. (2008). Probiotics: definition, sources, selection, and uses. Clinical infectious diseases, 46(2), 58-61. DOI: 10.1086/523341

Sullivan, Å., & Nord, C. E. (2002). The place of probiotics in human intestinal infections. International journal of antimicrobial agents, 20(5), 313-319. DOI: 10.1016/s0924-8579(02)00199-1

Matsuki, T., Watanabe, K., Fujimoto, J., Kado, Y., Takada, T., Matsumoto, K., & Tanaka, R. (2004). Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Applied and environmental microbiology, 70(1), 167-173. doi: 10.1128/AEM.70.1.167-173.2004

Toscano, M., Vecchi, E. D., Rodighiero, V., & Drago, L. (2013). Microbiological and genetic identification of some probiotics proposed for medical use in 2011. Journal of Chemotherapy, 25(3), 156-161. DOI: 10.1179/1973947812Y.0000000068

Ullah, M., Raza, A., Ye, L., & Yu, Z. (2019). Viability and composition validation of commercial probiotic products by selective culturing combined with next-generation sequencing. Microorganisms, 7(7), 188. DOI: 10.3390/microorganisms7070188

Vinderola, C. G., & Reinheimer, J. A. (1999). Culture media for the enumeration of Bifidobacterium bifidum and Lactobacillus acidophilus in the presence of yoghurt bacteria. International dairy journal, 9(8), 497-505. https://doi.org/10.1016/S0958-6946(99)00120-X

Weese, J. S., & Martin, H. (2011). Assessment of commercial probiotic bacterial contents and label accuracy. The Canadian veterinary journal, 52(1), 43.

World Health Organization. (1995). Constitution of the world health organization. Erişim Adresi: https://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf, [Erişim Tarihi: 26.09.2023].

Young, R. J., & Huffman, S. (2003). Probiotic use in children. Journal of Pediatric Health Care, 17(6), 277-283. DOI: 10.1016/s0891-5245(03)00070-1

Yayınlanmış

2024-01-19

Nasıl Atıf Yapılır

Yurdakul, Özen, Yılmaz, E. G., Şen, E., & Tutun, S. (2024). Tüketilen Bazı Probiyotik Preparatların İçerdiği Bakteri Seviyelerinin Belirlenerek PZR ile Doğrulanması. Türk Tarım - Gıda Bilim Ve Teknoloji Dergisi, 12(1), 59–65. https://doi.org/10.24925/turjaf.v12i1.59-65.6400

Sayı

Bölüm

Araştırma Makalesi